Literature DB >> 33483856

Factors associated with non-attendance in the Irish national diabetic retinopathy screening programme (INDEAR study report no. 2).

Stephen R Kelly1, Allison R Loiselle2, Rajiv Pandey3, Andrew Combes4, Colette Murphy5, Helen Kavanagh5, Patricia Fitzpatrick6,7, Therese Mooney6, Patricia Kearney8, David P Crabb9, David J Keegan3,5.   

Abstract

AIMS: We aimed to determine the patient and screening-level factors that are associated with non-attendance in the Irish National Diabetic Retinal screening programme (Diabetic RetinaScreen). To accomplish this, we modelled a selection of predictors derived from the historical screening records of patients with diabetes.
METHODS: In this cohort study, appointment data from the national diabetic retinopathy screening programme (RetinaScreen) were extracted and augmented using publicly available meteorological and geospatial data. A total of 653,969 appointments from 158,655 patients were included for analysis. Mixed-effects models (univariable and multivariable) were used to estimate the influence of several variables on non-attendance to screening appointments.
RESULTS: All variables considered for analysis were statistically significant. Variables of note, with meaningful effect, were age (OR: 1.23 per decade away from 70; 95% CI: [1.22-1.24]), type 2 diabetes (OR: 1.10; 95% CI: [1.06-1.14]) and socio-economic deprivation (OR: 1.12; 95% CI: [1.09-1.16]). A majority (52%) of missed appointments were from patients who had missed three or more appointments.
CONCLUSIONS: This study is the first to outline factors that are associated with non-attendance within the Irish national diabetic retinopathy screening service. In particular, when corrected for age and other factors, patients with type 2 diabetes had higher rates of non-attendance. Additionally, this is the first study of any diabetic screening programme to demonstrate that weather may influence attendance. This research provides unique insight to guide the implementation of an optimal and cost-effective intervention strategy to improve attendance.

Entities:  

Keywords:  Diabetic retinopathy; Public health; Screening; Socio-economic issues

Year:  2021        PMID: 33483856     DOI: 10.1007/s00592-021-01671-4

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  33 in total

1.  Screening compliance and visual outcome in diabetes.

Authors:  Gunnar Már Zoega; Thornóra Gunnarsdóttir; Sigríethur Björnsdóttir; Astradur B Hreietharsson; Guethmundur Viggósson; Einar Stefánsson
Journal:  Acta Ophthalmol Scand       Date:  2005-12

2.  Blindness in patients with diabetes who have been screened for eye disease.

Authors:  M C Rhatigan; G P Leese; J Ellis; A Ellingford; A D Morris; R W Newton; S T Roxburgh
Journal:  Eye (Lond)       Date:  1999-04       Impact factor: 3.775

3.  Cost implications, deprivation and geodemographic segmentation analysis of non-attenders (DNA) in an established diabetic retinopathy screening programme.

Authors:  Salman Waqar; Gill Bullen; Simon Chant; Rabia Salman; Bijay Vaidya; Roland Ling
Journal:  Diabetes Metab Syndr       Date:  2012-08-24

4.  The role of community pharmacists in the delivery of diabetes care.

Authors:  S Brewster; R I G Holt; J Portlock; H Price
Journal:  Diabet Med       Date:  2020-02-11       Impact factor: 4.359

Review 5.  Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review.

Authors:  Daniel Shu Wei Ting; Gemmy Chui Ming Cheung; Tien Yin Wong
Journal:  Clin Exp Ophthalmol       Date:  2016-02-17       Impact factor: 4.207

6.  Non-attendance at diabetic eye screening and risk of sight-threatening diabetic retinopathy: a population-based cohort study.

Authors:  Alice S Forster; Angus Forbes; Hiten Dodhia; Clare Connor; Alain Du Chemin; Sobha Sivaprasad; Samantha Mann; Martin C Gulliford
Journal:  Diabetologia       Date:  2013-06-22       Impact factor: 10.122

Review 7.  Diabetic retinopathy screening: global and local perspective.

Authors:  R A Gangwani; J X Lian; S M McGhee; D Wong; K Kw Li
Journal:  Hong Kong Med J       Date:  2016-08-26       Impact factor: 2.227

Review 8.  Global prevalence and major risk factors of diabetic retinopathy.

Authors:  Joanne W Y Yau; Sophie L Rogers; Ryo Kawasaki; Ecosse L Lamoureux; Jonathan W Kowalski; Toke Bek; Shih-Jen Chen; Jacqueline M Dekker; Astrid Fletcher; Jakob Grauslund; Steven Haffner; Richard F Hamman; M Kamran Ikram; Takamasa Kayama; Barbara E K Klein; Ronald Klein; Sannapaneni Krishnaiah; Korapat Mayurasakorn; Joseph P O'Hare; Trevor J Orchard; Massimo Porta; Mohan Rema; Monique S Roy; Tarun Sharma; Jonathan Shaw; Hugh Taylor; James M Tielsch; Rohit Varma; Jie Jin Wang; Ningli Wang; Sheila West; Liang Xu; Miho Yasuda; Xinzhi Zhang; Paul Mitchell; Tien Y Wong
Journal:  Diabetes Care       Date:  2012-02-01       Impact factor: 19.112

Review 9.  The English National Screening Programme for diabetic retinopathy 2003-2016.

Authors:  Peter H Scanlon
Journal:  Acta Diabetol       Date:  2017-02-22       Impact factor: 4.280

10.  Irish National Diabetic RetinaScreen Programme: report on five rounds of retinopathy screening and screen-positive referrals. (INDEAR study report no. 1).

Authors:  Rajiv Pandey; Margaret M Morgan; Colette Murphy; Helen Kavanagh; Robert Acheson; Mark Cahill; Patricia McGettrick; Louise O'Toole; Fatima Hamroush; Therese Mooney; Helen Byrne; Patricia Fitzpatrick; David J Keegan
Journal:  Br J Ophthalmol       Date:  2020-12-17       Impact factor: 4.638

View more
  2 in total

1.  Eighteen-year trends in the management of patients with diabetes in the Shiga Diabetes Clinical Survey: overall trends and differences by age group.

Authors:  Itsuko Miyazawa; Hiroshi Maegawa; Aya Kadota; Takashi Nakamura; Makoto Konishi; Shinichi Ochi; Katsuyuki Miura; Motozumi Okamoto
Journal:  Diabetol Int       Date:  2022-02-17

2.  Factors Affecting Compliance with Diabetic Retinopathy Screening: A Qualitative Study Comparing English and Spanish Speakers.

Authors:  Sharon M Hudson; Bobeck S Modjtahedi; Danielle Altman; Jennifer J Jimenez; Tiffany Q Luong; Donald S Fong
Journal:  Clin Ophthalmol       Date:  2022-04-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.